Cyfuse Biomedical KK (TSE:4892) EV-to-EBITDA : -4.53 (As of Apr. 26, 2024)

Cyfuse Biomedical KK EV-to-EBITDA Chart

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial				-16.89	-12.36	-8.97	-5.26	-5.67

Competitive Comparison of Cyfuse Biomedical KK's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyfuse Biomedical KK's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's EV-to-EBITDA falls into.

Cyfuse Biomedical KK EV-to-EBITDA Calculation

Cyfuse Biomedical KK's EV-to-EBITDA for today is calculated as:

Cyfuse Biomedical KK's current Enterprise Value is 円2,609.64 Mil.
Cyfuse Biomedical KK's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-576.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK  (TSE:4892) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cyfuse Biomedical KK's PE Ratio for today is calculated as:

Cyfuse Biomedical KK's share price for today is 円705.00.
Cyfuse Biomedical KK's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-75.423.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Cyfuse Biomedical KK EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description